Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Neurologic Complications of Cancer

Sunday 04/13/08
09:00 AM - 12:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
John W. Henson, MD, FÂ鶹´«Ã½Ó³»­
Participants should be familiar with the neurologic presentations of systemic cancer and be able to diagnose and recommend appropriate treatment for metastatic complications of cancer.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
09:00 AM - 09:45 AM Brain Metastasis
Roy A. Patchell, MD
09:45 AM - 10:30 AM Metastatic Epidural Spinal Cord Compression
Kurt A. Jaeckle, MD, FÂ鶹´«Ã½Ó³»­
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 AM Leptomeningeal Metastasis
Marc Chamberlain, MD
11:30 AM - 12:15 PM Paraneoplastic Neurologic Syndromes
Josep O. Dalmau, MD, PhD, FÂ鶹´«Ã½Ó³»­
12:15 PM - 12:45 PM Discussion
John W. Henson, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
John W. Henson, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Marc Chamberlain, MD No disclosure on file
Roy A. Patchell, MD No disclosure on file
Josep O. Dalmau, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Kurt A. Jaeckle, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jaeckle has stock in Entegrion, Inc.